Published on
September 4, 2019
- 11:00 GMT
Ocuphire Pharma Announces Completion of the First of Two Phase 2b Clinical Trials for Nyxol® Eye Drops
FARMINGTON HILLS, MICHIGAN, US, September 4, 2019 /EINPresswire.com/ -- Enrollment Completed for ORION-1 Phase 2b Glaucoma Trial with Data Expected in Q4 2019 Enrollment Near Completion for MIRA-1 Phase 2b Reversal of Mydriasis Trial with Data …
Distribution channels:
Banking, Finance & Investment Industry, Business & Economy
...
